Cardinal Health (NYSE:CAH) Insider Jessica Mayer Sells 29,436 Shares

Posted by Francis Steltz on Aug 20th, 2026

Cardinal Health, Inc. (NYSE:CAH – Get Free Report) insider Jessica Mayer sold 29,436 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the sale, the insider owned 33,076 shares in the company, valued at approximately $7,812,220.44. This represents a 47.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Cardinal Health Trading Down 0.1%

Cardinal Health stock opened at $234.73 on Thursday. The firm’s 50 day simple moving average is $231.76 and its 200 day simple moving average is $217.68. The firm has a market capitalization of $54.59 billion, a PE ratio of 32.47, a price-to-earnings-growth ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30.

Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Research analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors have recently modified their holdings of CAH. University of Texas Texas AM Investment Management Co. bought a new stake in Cardinal Health in the 4th quarter worth approximately $26,000. Bank of Jackson Hole Trust bought a new position in Cardinal Health during the fourth quarter valued at approximately $27,000. Jones Financial Companies Lllp grew its position in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Palladiem LLC purchased a new position in shares of Cardinal Health during the fourth quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co bought a new stake in shares of Cardinal Health in the 1st quarter worth approximately $29,000. 87.17% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CAH. Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Barclays upped their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a research report on Thursday, August 13th. Weiss Ratings raised shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research note on Wednesday, August 5th. Citigroup boosted their price target on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a research note on Wednesday, August 12th. Finally, Bank of America increased their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $266.56.

Check Out Our Latest Research Report on CAH

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.